However, it is likely that the Mpr1-PANPs we describe would be favored only in the treatment of already disseminated infections, both due to cytotoxicity concerns and the somewhat lower inhibitory concentrations we achieved with non-conjugated PNPs, and that other PANP configurations would be favored in non-disseminated infections. The gene discussed is IGF2R; the disease is infection.